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Abstract
In order for a successful infection and creating a satisfactory environment inside the 
host, strains of uropathogenic Escherichia coli (UPEC) need some special features that are 
achieved by expressing particular genes, called virulence factors. Two of the most impor-
tant surface virulence factors of UPEC are type 1 fimbriae and P fimbriae that are crucial 
for the colonization process inside the urinary tract. Expression of these virulence factors 
converts a commensal strain into an uropathogen. Beside these factors, outer membrane 
proteins also contribute to virulence being involved in the secretory machinery; an exam-
ple of such type is TolC protein that transfers α-hemolysin across the outer membrane of 
E. coli. However, α-hemolysin along with many other toxins serves various pathogenic 
roles during UTIs including adhesion, colonization, cytotoxic activity, etc. Moreover, 
virulence factors located on bacterial surface including capsule and lipopolysaccharides 
may also have the contribution to UTIs providing antiphagocytosis and antibactericidal 
complement activity.
Keywords: virulent factors, E. coli, UPEC, urinary tract infection, type 1 fimbriae,  
P fimbriae, α-hemolysin, cytotoxic necrotizing factor 1 (CNF1), siderophores,  
hemin uptake system, flagellar motility
1. Introduction
The most commonly living microorganism of the human gastrointestinal tract and also the 
most common causative agent of bacterial urinary tract infection is E. coli [1]. Though they 
remain in a good relationship with their hosts, they might appear as a subject of consider-
ation in immunocompromised hosts. This common inhabitant of the gastrointestinal tract 
usually remains in a symbiotic relationship with the host and plays a role in maintaining the 
homeostasis of the intestinal tract. Though most of the strains of E. coli are harmless, some 
serotypes can cause food poisoning. E. coli present in the normal human microbiota produces 
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. Strains of E coli, however, obtaining ability to colonize inside the urinary tract 
and to make themselves safe from the host immune system, become uropathogenic E. coli. 
UPEC causes >80% of UTI [2]. Urinary tract infections are very common, and approximately 
10% of people [3] and half of all women (at least one time) become infected throughout their 
life. According to a study, more than 100,000 patients in the United States are hospitalized 
annually due to urinary tract infections [4], and in the year 2011, 400,000 patients were hos-
pitalized, and the estimated cost was about 2.8 billion USD [5]. Infections can occur in both 
upper and lower urinary tracts. Lower urinary tract infection is known as cystitis, and in the 
case of upper urinary tract infection, it is called pyelonephritis. Without distinction of site, in 
order to cause infection, the causative agent must at first dodge the host’s immune system and 
colonize in the urinary tract [6]. Several different virulent factors are needed for the bacterial 
population to cause infections [7]; for instance, pathogenic strains of E. coli express adherence 
factors which form pili or fimbriae of different types for their attachment in the sites where 
they usually do not live [7]; these are structural virulence factors and predominantly include 
P fimbriae and type 1 fimbriae [1]. Fimbrial adhesins such as PapG and CsgA are virulence 
factors that facilitate the attachment of E. coli [8]. In animal models, type 1 fimbriae aggrandize 
the chance survival of E. coli [9]. Beside these, UPEC can impair host immune system by a 
variety of ways [10], such as toxins and iron acquisition systems, and these are called secreted 
virulence factors. The production of these virulence factors by UPEC may cause an inflamma-
tory response which makes a possible pathway for UTI symptoms [1]. However, both the host 
and the uropathogenic E. coli strain have different roles in the establishment and colonization 
process in the urinary tract [11]. Here in this chapter, different types of important virulence 
factors of uropathogenic E. coli will be discussed.
In Gram-negative and some Gram-positive bacteria, virulence genes are allocated in particular 
segments (about 10–200 kilo bases in size) of their genome which have different G + C content 
than the other parts of the genome that are termed as pathogenicity islands. They are present 
in the virulent strains but present rarely in the nonpathogenic strains of the same species. 
These sequences can be transferred horizontally from species to species [12]. Pathogenicity 
islands encode virulence factors such as adherence factors, toxins, and iron acquisition sys-
tems which are important virulence factors of UPEC.
2. Adhesion
Urine of uninfected person is sterile due to urinary flow and antimicrobial activity of uric 
acid. Regular flow of urine does not allow microorganism to colonize inside the urinary tract. 
However, attachment of E. coli to uroepithelial cells allows them to overwhelm the effect of 
urine flow. For many pathogenic microorganisms, it is considered as the first step in the colo-
nization process [13, 14], and both the host and E. coli function in this process. The ability of 
UPEC to colonize depends upon the expression of different fimbrial adhesins. For a successful 
adherence to the host cell surface, UPEC expresses many adherence factors which are crucial 
for attachment and thus regarded as virulence factors. Many bacterial adhesins are organized in 
a thin filamentous structure called fimbriae or pili although there are evidences of presence of 
adhesins in the cell surface of bacteria. Adhesins of fimbrial nature are important during attach-
ment process [15]. Fimbriae, also known as pili, are long hair-like structures contained in the cell 
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surface of bacteria that recognize specific compounds usually carbohydrates of the target host 
cells [11]. Pili are the short form of fimbriae and might be used interchangeably with fimbriae. 
Fimbriae consist of oligomeric pilin proteins. These proteins are arranged in such a manner that 
they form a helical cylindrical structure and are both thinner and shorter than flagellum. These 
proteinaceous structures are expressed in uropathogenic strains of E. coli and are considered as 
virulence factors [11]. Most of the receptors for these fimbriae are carbohydrates. They include 
type 1 fimbriae, P fimbriae, and thin aggregative fimbriae [16]. Many bacterial pathogens can 
produce an array of these adhesins, and often inhibition of a single adhesin may cost enough to 
a bacterium to lose its virulence. Functions of pili or fimbriae are not limited only to adhesion 
and can help in many other crucial pathways for the microbe to survive and evade the immune 
system of the host. Evolution of different types of adhesins plays a role in tissue tropism.
In gram-negative bacteria like UPEC, adhesins are unveiled by chaperone-usher-assisted 
pathway. This pathway involves two proteins, one is a periplasmic chaperone, and the other 
is a protein called usher. Usher act as the base of the structure, and the function of chaperone 
is folding and recruitment of the subunits [17, 18]. In absence of the chaperone, pilin proteins 
are degraded and misfolded and thus cannot be assembled in the form of a mature pilus. On 
the other hand, usher helps to mature the fimbriae and its transportation through the outer 
assuring integrity of the outer membrane. The constituents of usher proteins are an N-terminal 
domain (NTD), 24-stranded beta-barrel channel, a plug domain, and two C-terminal domains 
(CTD). In uropathogenic E. coli strains, chaperone-usher family fimbriae are more abundant.
2.1. Type 1 fimbriae
In 99% of E. coli strains, genes to encode type 1 fimbriae are present [19], and during urinary 
tract infections, they damage urinary tract cells by mediating an increased inflammation [20]. 
In order to enter into the host cells of the urinary tract, type 1 fimbriae play a great role. 
Type 1 fimbriae are remarkably versatile virulence factors of UPEC that can stabilize the 
attachment of the bacteria to different type of cells throughout the urinary tract. Though 
in Bowman’s capsules and glomerulus their binding sites could not be identified, a strong 
affinity of type 1 fimbriae was found in proximal tubules and vessel walls. In the bladder, 
they bind strongly to muscular layers and moderately to vessel walls. Receptors for type 1 
fimbriae were also found in the distal tubules and collecting ducts. They can also induce their 
binding to the surface of macrophages [9]. These fimbriae recognize uroplakin from blad-
der epithelial cells and mannoside-containing host proteins. Unlike many other important 
types of adhesins, these are encoded by the bacterial backbone DNA [21] and are mainly 
composed of FimA proteins along with FimF, FimG, and FimH [17]. FimA proteins are most 
in number but are not pivotal for virulence. Among other subunits of type 1 fimbriae, allelic 
variations of FimH determine the sugar specificity and deletion of fimH results in less amount 
of colonization in mouse models of ascending UTI, and colonization could be restored by 
expression of plasmid with fimH gene [20]. FimH alone or in association with LPS can stimu-
late toll-like receptor 4 (TLR4) to initiate particular signaling cascade that may activate the 
humoral immune response. Many studies revealed that expression of type 1 fimbriae results 
in virulence and loss of expression results in loss of expression but their presence cannot be 
correlated with UTI as normal fecal strains also have equally expressed type 1 fimbriae [22]. 
However, type 1 fimbriae-mediated attachment is a crucial stage for cystitis. Adhesins of 
these fimbriae are mannose sensitive.




P-fimbriated E. coli are pyelonephritogenic and attach to the carbohydrate structure alpha-D-
Galp-(1-4)-beta-D-Galp. In the kidney, they bind strongly to Bowman’s capsule, glomerulus, 
and endothelial cells of vessel walls. This highly organized composite structure is composed 
of six subunits at least. Once P fimbriae expressed E. coli enter the urinary tract, they establish 
bacteriuria and help to cross the epithelial barrier to enter the bloodstream and can cause 
hemagglutination of erythrocytes [14]. This type of fimbriae is encoded by pap gene cluster 
(also known as fso and fst), and pap + strains remain longer in the intestinal flora than pap- 
strains [23]. P antigens are expressed in the cell surface of red blood cells and in various cells 
lining in the urinary tract. P1 (present in glycoproteins in human), P, PK, and LKE antigens act 
as the receptors for P-fimbriated UPEC. P-fimbriated E. coli cannot agglutinate red blood cells 
that lack P antigen. Isolated P fimbriae can bind to a synthetic analogue of its receptor, and 
experimental application of that analogue impedes infection process.
There are at least nine genes in the pap gene cluster with two restriction sites at two ends. 
The regulatory part starts the following Eco R1 consisting of papI and papB. Then papA, 
papH, papC, papD, papE, papF, and papG are situated, and after these, Bam HI is present. 
Approximately 1000 of subunits form a P fimbria, being united in a helical manner. Among 
them the major constituent is the protein subunit PapA (19.5 KD), and minor subunits are 
PapE (16.5 KD), PapF (15 KD), and PapG (35 KD). In the periplasmic space, PapD (27.5 KD) 
may be present and can also be incorporated in the structure. Another protein PapC, which 
is the largest one with 80 KD of mass, assists the process by transporting the subunits outside 
the part of the cell. Though PapA is the major constituent, it is not mandatory for attachment, 
and among many serotypes, PapA molecules show high homology with the amino acids of N 
and C termini. PapA also has an average level of similarity with structural subunits of other 
E. coli fimbriae including type 1 fimbriae. The minor subunits at the tip of fimbria determine 
the specificity to the receptor. Many mutational analyses revealed that mutation in PapA does 
not affect the adherence, while mutation in other genes (i.e. papEFG) does not hamper fimbrial 
structural appearance. In the fine structure of P fimbriae, a PapF-PapG complex is formed 
which is attached to PapA (bulk potion of the structure) subunits through PapE subunits. 
Finally, PapH terminates the assembly of the fimbriae and attaches thereby [16]. An important 
thing is that the amino acid sequence of PapG is approximately similar to that of Shiga toxin. 
Shiga toxin is found in some serotypes of E. coli. Another role of PapG was found in some 
variants of P fimbriae which is they can initiate subunit polymerization [14].
Many experiments show that expression of these fimbriae is not relevant to urinary tract infec-
tion, while more sophisticated other experiments have concluded about their role in patho-
genesis. However, during infection in immunocompromised patients, less expression of P 
fimbriae is observed, which indicated that P fimbriae are needed to overcome certain types of 
host immune attacks. Although P fimbriae can initiate inflammatory responses by activating 
TLR4 [24], it protects UPEC from human polymorphonuclear leukocytes (hPMNLs). In the 
rapidly changing environment through the urinary tract, environmental influences affect the 
expression of P fimbriae. Expression of P fimbriae is favored at 37°C and inhibited at a range 
of 18–22 °C, but there are some variations in this phenomenon. The temperature-dependent 
expression is controlled by a region close to papB of the pap gene cluster.
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2.3. Dr/Afa adhesins
Dr blood group antigen is a membrane protein of red blood cells and located on the decay 
accelerating factor (DAF) that protects red blood cells from being degraded or lysed by 
autologous complements. Another important function of DAF is to regulate complement 
cascade [25]. These antigens are recognized by Dr and Afa adhesin family of uropathogenic 
E. coli. There are both fimbrial (F1845 and O75X) and non-fimbrial (AFA I and AFA II) types 
of adhesins. Immuno-invasion of UPEC by hiding from the host humoral immune response 
is somehow mediated by Dr family of adhesins [26]. These microscopically invisible fimbriae 
are present in the cell wall, and their structural and organization properties are quite different 
from other types of fimbriae [13]. Chloramphenicol can inhibit O75X binding to a specific 
part of the Dr antigen, but it cannot inhibit other adhesins of this family which indicates that 
Dr family adhesins can recognize specific sites at the Dr [25]. For years, several studies were 
conducted to identify specific sites for binging of Dr family hemagglutinins. For instance, a 
strong affinity of O75X was found to Bowman’s capsule, proximal and distal tubules, and the 
collecting duct basement membranes. In the bladder, they strongly bind to connective tissues.
2.4. Other fimbriae as virulence factors
F1C is a virulence factor responsible for urinary tract infections, which is encoded by an 
operon of seven genes, i.e., focAICDFGH, where FocA is the major subunit and FocH is the 
tip adhesin [26]. F1C receptors are present in bladder endothelium and muscular layer. They 
cannot bind to the epithelium. They bind to glomeruli, distal tubules, collecting ducts, and 
vascular endothelial cells. Studies show that F1C fimbriae and pyelonephritis are correlated 
though there is a little difference in the prevalence of type 1 fimbriae in UTI strains and nor-
mal fecal isolates. Prevalence of F1C fimbriae in normal fecal isolates is 10% which is 16% in 
UTI strains [26]. S fimbriae are genetically identical to F1C fimbriae and differ only by the tip 
adhesin SfaS. Criteria that are needed to be recognized as a virulence factor were determined 
by different studies regarding S fimbriae. There are some other adhesins that are not crucial 
for the survival of UPEC strains such as F9 fimbriae.
3. Toxins
Several toxic substances or proteins secreted by uropathogenic strains of E. coli play a conse-
quential role as virulence factors in UTIs. However, toxins have the ability to alter the host cell 
signaling cascade and modulate inflammatory responses. Several in vitro and in vivo studies 
showed that toxins also contribute to the stimulation of the host cell death and releasing of 
necessary nutrients, which provide the ability to access deeper tissues within the urinary 
tract [27]. In 1987, CDT toxin (cyclomodulins) was first reported as virulent toxin in UPEC 
[28] which opened a new door in the study of the pathogenesis of UTIs, and then many other 
toxins in UPEC were reported including α-hemolysin (HlyA), cytotoxic necrotizing factor 
1 (CNF1), secreted autotransporter toxin (SAT), cytolysin A, plasmid-encoded toxin (PET), 
vacuolating autotransporter toxin (VAT), Shigella enterotoxin-1 (ShET-1), arginine succinyl-
transferase (AST), etc.




Among all the toxins, α-hemolysin (HlyA) is very important which is a lipoprotein and belongs 
to the RTX (repeats in toxin) toxins family [13, 29, 30]. HlyA is a pore-forming toxin and causes 
inducible nitric-oxide-synthase (iNOS)-mediated cell membrane injury and apoptosis [31]. 
However, HlyA can lyse erythrocytes and nucleated host cells at high concentration by a process 
enabling UPEC which may damage the host immune effector cells for gaining enhanced access 
to the host nutrients and iron stores. But when the concentration is low, HlyA can induce the 
apoptosis of target host cells and promote the exfoliation of bladder epithelial cells [13, 32, 33]. 
Besides, HlyA can also contribute to nephropathogenicity, which was proved by infecting mice 
transurethrally or intravesically with toxin producer and nonproducer isogenic clone pairs of 
E. coli [34]. A recent study showed that HlyA regulates the dephosphorylation of Akt, which is 
a multifunctional signaling regulator and responsible for controlling inflammatory responses 
in the host, as well as the cell cycle control [35]. Moreover, HlyA has the role in the increased 
production of IL-6 and IL-8 by inducing Ca2+ oscillations in renal epithelial cells [36].
3.2. Cytotoxic necrotizing factor 1 (CNF1)
Another virulence factor secreted by E. coli named cytotoxic necrotizing factor 1 (CNF1) is 
also involved in UTIs and stimulates actin stress fiber formation and membrane ruffle forma-
tion in a Rho GTPase-dependent manner that results in the entry of E. coli into the cells [37]. 
The toxin has a remarkable effect on the actin skeletal of HEp-2 cells and produces large 
vacuoles in HEp-2 cells [28]. However, several in vitro and in vivo studies showed that this 
protein interferes with polymorphonuclear phagocytosis and evokes apoptotic death of blad-
der epithelial cells and may lead to bladder cell exfoliation and to enhanced bacterial access 
to underlying tissue [38, 39]. In addition, there is also a possibility of the association of CNF1 
with the hemolysin in the virulence mechanism, which is beneficial for the bacteria [28].
3.3. Secreted autotransporter toxin (SAT)
Secreted autotransporter toxin (SAT) may also be important as a virulence factor for the 
pathogenesis of UTIs being had a toxin activity against cell lines of bladder or kidney origin. 
SAT is a serine protease autotransporter which falls within one subgroup of autotransporters 
recently classified as the SPATE (serine protease autotransporters of Enterobacteriaceae) fam-
ily and associated with pyelonephritic E. coli strains [40, 41]. SAT may have the cytopathic 
activity that results in the damage of the host tissue and may increase the propagation ability 
of the UPEC. However, this toxin may facilitate entry of pyelonephritogenic strains into the 
bloodstream resulting from specific damage to the glomeruli and proximal tubules [40].
3.4. Cytolethal distending toxin (CDT)
Cytolethal distending toxin, having a unique property of damaging the DNA of the target 
cell, was first reported in pathogenic E. coli in 1987 [28, 42]. This toxin has the ability to arrest 
the cell cycle and contributes to the pathogenesis of UTIs [43, 44]. However, CDT is an operon 
product encoding three proteins including CdtA, CdtB, and CdtC proteins which are encoded 
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by cdtA, cdtB, and cdtC genes, respectively [28]. CDT has DNase I-like enzymatic activity and 
attacks DNA, while the other bacterial toxins attack the cell membrane or different targets 
within the cytoplasm [45]. This unique property of attacking DNA damages the target cell 
DNA which results in progressive cell distending leading to cell death [27].
3.5. Other toxins
Some others including cytolysin A and toll/interleukin (IL-1) receptor (TIR) domain-contain-
ing protein (Tcp) are also considered as virulence factors in UTIs [46, 47]. The former causes 
apoptosis of the host cells [47], while the other has the ability to subvert TLR signaling that 
gives a survival advantage during UTIs [46]. However, Tcp is associated with pyelonephritis 
but rare in environmental E. coli, in fecal flora of healthy children and in less severe forms of 
UTI [27]. Besides these, Tcp has also the role in the human avoidance system and cytopathic 
effect on the kidney [48].
In addition to these toxins, vacuolating autotransporter toxin (VAT), Shigella enterotoxin-1 
(ShET-1) and arginine succinyltransferase (AST) may also contribute to UTIs. VAT has the 
cytotoxic effect on the bladder and kidney, while the two others are involved in the invasion 
of the infections [48]. However, VAT is a highly protected immunogenic protein that belongs 
to the protease family of SPATE [28].
4. Siderophores
Iron is a very important molecule for all living beings, and E. coli uses iron for transport-
ing and storing oxygen, DNA synthesis, electron transport, and metabolism of peroxides. 
But the amount of iron availability is reduced in the host urinary tract during UTIs [49]. In 
response to this, E. coli possesses some multiple functionally redundant systems that mediate 
iron uptake by secreting low-molecular-weight Fe3+-chelating molecules which are known as 
siderophores [50]. Iron utilization, mediated by these siderophores, is critical for colonization 
of the urinary tract by UPEC [51]. There are four distinct siderophore systems found in E. 
coli such as yersiniabactin, aerobactin, enterobactin, and salmochelin [52]. These systems also 
include some genes such as ent genes encoding enterobactin, iuc genes encoding aerobactin, 
and iro genes encoding an ent-like system. However, all these systems are expressed under 
low-iron conditions and are negatively regulated by ferrous iron and the ferric uptake regula-
tor Fur [53].
4.1. Aerobactin
Aerobactin is a low-weight molecule and a hydroxamate siderophore with a higher Fe3+-
binding stability in acidic environments and is maximally produced at low pH [44, 53]. This 
siderophore extracts Fe3+ from host iron-binding proteins and is taken up through an outer 
membrane receptor protein [44]. However, aerobactin has many advantages over other sid-
erophores and is formed from the condensation of two lysine molecules and one citrate cata-
lyzed by an enzyme named aerobactin synthase [13, 25, 30].




Enterobactin is another specialized highly prevalent catecholate siderophore which is less 
soluble and less stable than aerobactin [53–55]. But this siderophore has a higher iron affin-
ity and can deferrate transferrin more rapidly than aerobactin in aqueous solution [13, 54]. 
However, iron is released from enterobactin through the hydrolysis of this siderophore [13]. 
Besides these, enterobactin may afford UPEC the ability to colonize within an iron-limiting 
environment such as the urinary tract [56]. But this siderophore has a limitation that it can be 
inactivated by host proteins such as serum albumin and siderocalin [25].
4.3. Yersiniabactin
Yersiniabactin, a mixed-type siderophore, is widespread in Enterobacteriaceae including E. coli 
and encoded on the high-pathogenicity island [53]. Yersiniabactin has a high iron affinity 
and produced yersiniabactin-Fe3+ complex binding to the iron molecule which recognizes the 
specific bacterial outer membrane TonB-dependent receptor and Fyu (Psn). The iron molecule 
is released from yersiniabactin in the cytosol with the help of membrane-embedded proteins 
[57]. In addition, this siderophore increases resistance to copper stress by chelating Cu2+ [10].
4.4. Salmochelin
Salmochelin is a glucosylated derivative of enterobactin which is not recognized by sidero-
calin and thus escapes from the host immune response [53]. However, siderocalin, neutro-
phil gelatinase-associated lipocalin is also known as lipocalin 2 that binds enterobactin and 
prevents its uptake [53, 56]. To overcome this, enterobactin is modified to salmochelin by 
glucosylation via the action of glucosyltransferase and is not recognized by lipocalin 2 [56]. 
However, a recent study found that salmochelin siderophore receptor IroN is involved in 
the invasion of urothelial cells, and thus IroN may play both an iron uptake receptor and an 
internalization factor in the establishment of urinary tract infections [26].
4.5. Hemin uptake system
There is another iron acquisition system called hemin uptake system including ChuA and Hma, 
which involves direct upregulation of haem receptors. This system uptakes free iron during 
UTIs, and several studies found its role in bacterial growth and biofilm formation [48, 58, 59]. 
ChuA expression is regulated by other regulatory proteins, for instance, in uropathogenic E. coli 
strain 536, increase in RfaH level induces the expression of ChuA [60]. But the other receptor 
Hma functions independently of ChuA, and a residue, Tyr-126, is necessary for its function. 
However, both ChuA and Hma contribute to haem utilization which is required for the maxi-
mum kidney colonization [51].
5. Capsule
The main role of a capsule is to cover and protect the bacterium from various unfavorable con-
ditions as well as the host immune system, which is mainly constituted of polysaccharide [1]. 
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The capsule provides protection against engulfment and complement-mediated bactericidal 
effect in the host, also including antimicrobial resistance and antiserum activity [1, 48]. Certain 
capsulars, such as K1 and K5, prevent a proper humoral immune response of the infected host 
by showing a molecular mimicry to tissue components [1]. The K1 polysaccharide, a linear 
α2–8-linked sialic acid homopolymer, has a very important role in IBC development as well 
as in the multiple stages of UTI pathogenesis [27, 50].
6. Lipopolysaccharide
Lipopolysaccharide (LPS) is an integral component of the cell wall and consists of the highly 
conserved lipid A-core and repeating O-antigen subunits that differ greatly between strains 
based on the sugar residues and their linkage patterns within the repeating subunits [37, 61]. 
LPS is very well known to activate host response and to induce nitric oxide and cytokine (IL-1, 
TNF-α) production which enhances the inflammatory response [1, 15]. It also induces the syn-
thesis of specific antibodies to the somatic antigen and exerts an immune-adjuvant effect that 
promotes the humoral immune response to other antigens of the pathogen. However, certain 
antigenic types of LPS are also involved in resistance of the pathogen to the killing effect of 
the normal human serum [46]. According to study upon animal models, acute renal failure 
due to LPS depends on the systemic response to LPS and does not depend on expression of 
functional LPS receptor, TLR4, in the kidney. But it is not clear whether LPS plays a role in 
mediating a renal failure and acute allograft injury in patients with ascending UTIs [1].
7. Motility
Flagellum is an organelle that is responsible for bacterial motility and plays a role in the initial 
adhesion phase of biofilm formation [1, 62]. A recent study showed that motility is involved 
in the migration of the infection from the bladder to the kidneys [63]. About 70–90% of all 
urinary tract infections is caused by flagellated UPEC, and pathogenesis involves contact 
between the bacteria and epithelial cell surface of the urinary tract [1]. However, flagellar 
motility enhances the ability of E. coli by adaptive responses to attractive or repellent environ-
mental stimuli [15].
8. Mechanism of immune escape
Toll-like receptor 4 (TLR4) in the epithelial cells of the mammalian bladder can recognize lipo-
polysaccharides (LPS) of bacterial cell wall, and the downstream signaling cascade produces IL-6 
and IL-8, of which IL-8 is well known as an important chemoattractant for neutrophils. Urinary 
levels of IL-6 and IL-8 are measurable in UPEC-infected human and murine models. There is 
another pathway parallel to this one that is responsible for increased levels of IL-6 and IL-8 in 
urine. Upon TLR-4 activation by LPS, intracellular level of cAMP is increased and results in of 
Ca2+ influx. Later, cAMP response element-binding protein (CREB) becomes phosphorylated. 
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Phosphorylation of CREB results in the expression of IL-6 and IL-8 [24]. Mutation in TLR4 in 
murine models revealed its role on bacterial pathogenesis. There are other receptors related to 
UTI pathogenesis. One of such is CXCR1, but there are both types of evidences that demonstrate 
the positive and “no correlation” of CXCR1 with recurrent UTIs. Polymorphisms in IL-8 genes 
were found to have a correlation with pyelonephritis in the case of no correlation with CXCR1 
mutation [19, 64]. TLR4 can be activated by the presence of type 1 fimbriae and P fimbriae.
As there are enough studies to evidence the activation of immune response against UPEC 
strains, there must be some ways that are used by these bacteria to overcome unfavorable situ-
ations early in the infection. Incubation of human urothelial cells with type 1-fimbriated UPEC 
strains resulted in increased apoptosis. In the case of a nonpathogenic type 1-fimbriated strain 
(HB101) of E. coli, rate of apoptosis was approximately 50% of that of pathogenic strains of UPEC 
[65]. UPEC blocks NF-ĸB, and this results in apoptosis and a decreased cytokine secretion.
Another indispensable way is the expression of toll/IL-1 receptor domain-containing protein 
(TcpC), which was discovered in UPEC strain CFT073. TcpC interacts with myeloid differen-
tiation primary response 88 (MyD88), a protein that, in human, is encoded by MYD88 gene. 
Interaction of TcpC and MyD88 subsequently stops downstream signaling pathways medi-
ated by TLRs.
Modification of capsular lipopolysaccharides specific to the pathogenic strain can cause the 
failure of TLR4 to recognize the pathogen. However, LPS biosynthetic genes encoded by rfa, 
rfb operons, and surA are the factors responsible for the suppression of TLR-initiated signal-
ing cascades. Biosynthesis of a number of outer membrane proteins and fimbriae is facilitated 
by the protein encoded by surA, which is a periplasmic cis-trans prolyl isomerase [66, 67].
9. Conclusions
Several epidemiological, serological, and bacteriological studies revealed that uropathogenic 
E. coli is the pathogen most frequently associated with UTIs. In recent years, our understand-
ing of virulence factors and behavior of this pathogen is increased remarkably. Several studies 
showed that E. coli colonizes the urinary tract and may ascend toward the bladder to cause 
cystitis. If it is left untreated, UPEC may ascend the ureters to the kidney and establish a 
secondary infection. Our increased understanding of its virulence factors can uncover novel 
approaches to control UPEC-mediated UTIs. However, accumulation of theoretical knowl-
edge through virulence studies allows practical applications and may facilitate the applica-
tion of more precise approaches in phenotypic or molecular diagnosis and epidemiology.
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